Anat Naschitz

Anat Naschitz General Information

Biography

Ms. Anat Naschitz is a Co-Founder and serves as Chief Executive Officer at 9xchange. Ms. Naschitz serves as Managing Partner at 9vc. She serves as Board Member at Noga Therapeutics and POLARISqb. She served as Venture Partner at OrbiMed. She served as Board Member at Azura Ophthalmics, MDClone, Nutrinia, and TytoCare. Ms. Naschitz is also a Board Member of 89bio. She has more than 20 years of healthcare experience. She began her healthcare focus at McKinsey and Company in London, where she was an Associate Partner managing strategy and M&A projects for some of the world's top pharmaceutical and biotechnology companies. Among her accomplishments, Ms. Naschitz successfully led spinouts that resulted in the creation of two European biotech companies, which completed IPOs for more than $1 billion. She has since focused her career on managing life sciences investments, initially at Apax and then at OrbiMed. She currently serves on the boards of biotech, digital health, and medical device companies. She earned her MBA at INSEAD and her LLB at Tel Aviv University.